Essential Oils and COVID-19

被引:19
作者
Elsebai, Mahmoud Fahmi [1 ]
Albalawi, Marzough Aziz [2 ]
机构
[1] Mansoura Univ, Fac Pharm, Dept Pharmacognosy, Mansoura 35516, Egypt
[2] Univ Tabuk, Alwajh Coll, Dept Chem, Tabuk 47512, Saudi Arabia
来源
MOLECULES | 2022年 / 27卷 / 22期
关键词
essential oils; COVID-19; SARS-CoV-2; eucalyptol; garlic oil; natural products; OREGANO ESSENTIAL OIL; SIMPLEX-VIRUS TYPE-1; IN-VITRO; ANTIVIRAL ACTIVITY; INFLUENZA-VIRUS; OXIDATIVE STRESS; ALLIUM-SATIVUM; EXPRESSION; INFECTION; CARVACROL;
D O I
10.3390/molecules27227893
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Herbal products are a major source of herbal medicines and other medicines. Essential oils have shown various pharmacological activities, such as antiviral activity, and therefore are proposed to have potential activity against SARS-CoV-2. Due to their lipophilicity, essential oils can easily penetrate the viral membrane and cause the viral membrane to rupture. In addition, crude essential oils usually have many active constituents that can act on different parts of the virus including its cell entry, translation, transcription, and assembly. They have further beneficial pharmacological effects on the host's respiratory system, including anti-inflammatory, immune regulation, bronchiectasis, and mucolytics. This review reported potential essential oils which could be promising drugs for COVID-19 eradication. Essential oils have many advantages because they are promising volatile antiviral molecules, making them potential drug targets for the prevention and treatment of COVID-19, whether used alone or in combination with other chemotherapeutic drugs. The aim of the current review is to shed light on the potential essential oils against enveloped viruses and their proposed activity against SARS-CoV-2 which is also an enveloped virus. The objectives were to present all data reflecting the promising activities of diverse essential oils against enveloped viruses and how they could contribute to the eradication of COVID disease, especially in indoor places. The data collected for the current review were obtained through the SciFinder database, Google scholar, PubMed, and Mendeley database. The data of the current review focused on the most common essential oils which are available in the pharmaceutical market and showed noticeable activities against enveloped viruses such as HSV and influenza.
引用
收藏
页数:12
相关论文
共 104 条
  • [1] [Anonymous], 2020, Eucalyptol (1, 8 cineole) from eucalyptus essential oil a potential inhibitor of COVID 19 corona virus infection by molecular docking studies, DOI DOI 10.20944/PREPRINTS202003.0455.V1
  • [2] Immunomodulation and Anti-Inflammatory Effects of Garlic Compounds
    Arreola, Rodrigo
    Quintero-Fabian, Saray
    Ivette Lopez-Roa, Rocio
    Octavio Flores-Gutierrez, Enrique
    Pablo Reyes-Grajeda, Juan
    Carrera-Quintanar, Lucrecia
    Ortuno-Sahagun, Daniel
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [3] COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties
    Asif, Muhammad
    Saleem, Mohammad
    Saadullah, Malik
    Yaseen, Hafiza Sidra
    Al Zarzour, Raghdaa
    [J]. INFLAMMOPHARMACOLOGY, 2020, 28 (05) : 1153 - 1161
  • [4] Comparative Study on the Antiviral Activity of Selected Monoterpenes Derived from Essential Oils
    Astani, Akram
    Reichling, Juergen
    Schnitzler, Paul
    [J]. PHYTOTHERAPY RESEARCH, 2010, 24 (05) : 673 - 679
  • [5] An Overview on the Anti-inflammatory Potential and Antioxidant Profile of Eugenol
    Barboza, Joice Nascimento
    Maia Bezerra Filho, Carlos da Silva
    Silva, Renan Oliveira
    Medeiros, Jand Venes R.
    de Sousa, Damiao Pergentino
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018
  • [6] Essential Oils in Combination and Their Antimicrobial Properties
    Bassole, Imael Henri Nestor
    Juliani, H. Rodolfo
    [J]. MOLECULES, 2012, 17 (04): : 3989 - 4006
  • [7] Bastaki SMA, 2018, AM J TRANSL RES, V10, P4210
  • [8] Benencia F, 2000, PHYTOTHER RES, V14, P495, DOI 10.1002/1099-1573(200011)14:7<495::AID-PTR650>3.0.CO
  • [9] 2-8
  • [10] Berger William, 2009, Current Drug Delivery, V6, P38